Trump Holds Meeting with Pharmaceutical Leaders, Regeneron Announces Price Reductions
Washington – Donald Trump met with directors of several American pharmaceutical companies and government ministers on Thursday at the White House to discuss healthcare accessibility within the United States. The meeting centered on agreements designed to improve patient access to medications. Among the participants was biotech firm Regeneron, which announced a reduction in drug prices for a select group of American patients as part of the collaborative arrangement with the Trump administration.
Details of the agreement were outlined to reporters following the meeting. During the discussion, cameras recorded President Trump exhibiting a brief lapse in attention. At one point, he closed his eyes and subsequently fell asleep.
He later opened his eyes and repeated the action. American media outlets noted that this behavior echoes previous criticisms leveled by President Trump against his predecessor, Joe Biden, who has often been referred to as “sleepy” during public appearances. The meeting represents an ongoing effort to address healthcare challenges, with pharmaceutical companies playing a key role in the discussions.
Further details regarding the scope of the agreements are expected to be released in the coming days. The cameras captured a notable moment during the event.
Topics: #trump #meeting #cameras
It’s disheartening to see a former president seemingly disengaged during such a significant discussion.